By Aditi Shivarkar, insightSLICE
According to new analysis at insightSLICE, the global generic sterile injectable market size was estimated to be $80 billion in 2022 and is expected to grow to reach $159 billion by 2032. Let's dig into the key factors driving this growth.
|